US8718291078 - Common Stock - After market: 76.72 0 (0%)
Date | Firm | Action | Rating |
---|---|---|---|
2023-02-02 | Argus Research | Downgrade | Buy -> Hold |
2023-02-01 | BMO Capital | Maintains | Outperform |
2023-02-01 | Deutsche Bank | Maintains | Hold |
2023-02-01 | Barclays | Maintains | Overweight |
2023-02-01 | Truist Securities | Maintains | Buy |
2023-02-01 | Credit Suisse | Maintains | Outperform |
2023-02-01 | Morgan Stanley | Maintains | Equal-Weight |
2023-01-18 | Morgan Stanley | Maintains | Equal-Weight |
2023-01-13 | Stephens & Co. | Reiterate | Overweight |
2023-01-04 | Wells Fargo | Maintains | Overweight |
2022-11-02 | Argus Research | Maintains | Buy |
2022-11-02 | Morgan Stanley | Maintains | Equal-Weight |
2022-10-20 | Barclays | Maintains | Overweight |
2022-10-11 | Morgan Stanley | Maintains | Equal-Weight |
2022-09-23 | Stephens & Co. | Initiate | Overweight |
2022-08-10 | Truist Securities | Maintains | Buy |
2022-08-10 | Credit Suisse | Maintains | Outperform |
2022-06-29 | Barclays | Maintains | Overweight |
2022-06-09 | Barclays | Maintains | Overweight |
2022-05-26 | JP Morgan | Upgrade | Neutral -> Overweight |
2022-05-11 | Credit Suisse | Maintains | Outperform |
2022-05-11 | Morgan Stanley | Maintains | Equal-Weight |
2022-04-25 | Barclays | Maintains | Overweight |
2022-04-08 | Piper Sandler | Maintains | Overweight |
2022-03-11 | CL King | Initiate | Neutral |
2022-02-22 | Argus Research | Upgrade | Hold -> Buy |
2022-02-09 | Morgan Stanley | Maintains | Equal-Weight |
2022-02-01 | Truist Securities | Initiate | Buy |
2022-01-14 | Morgan Stanley | Maintains | Equal-Weight |
2022-01-04 | Deutsche Bank | Initiate | Hold |
Find the competitors with the best analyst ratings on the USA